[Plea for advancement of the age of vaccination against human papillomavirus in France: Position of the Pediatric Infections Pathology Group (GPIP) and the French Association of Ambulatory Pediatrics (AFPA)]

Autor: R, Cohen, F, Vié Le Sage, C, Weil-Olivier, O, Romain, I, Hau, N, Guérin, G, Thiebault, B, Virey, P, Bakhache, M-A, Dommergues, J, Gaudelus
Jazyk: francouzština
Rok vydání: 2012
Předmět:
Zdroj: Archives de pediatrie : organe officiel de la Societe francaise de pediatrie. 19
ISSN: 1769-664X
Popis: Vaccination against human papillomavirus (HPV) is recommended in France at 14 years. The Groupe de Pathologie Infectieuse Pédiatrique de la Société Française de Pédiatrie takes a clear position for advancement of age of vaccination at 11-12 years based on the following arguments: (i) data on the long-term persistence of protective antibodies are reassuring; (ii) these vaccines can be co-administered with vaccines recommended in the current immunization schedule at this age; (iii) actually, nearly 20% of adolescents have had sexual intercourse when the vaccination schedule is finished; (iv) vaccination beyond 14 years increases the risk of occurrence of coincidental autoimmune diseases; (v) the immunogenicity of vaccines against HPV is better when they are administered before age 15; (vi) finally, especially by reducing the number of injections from 3 to 2, the immunization at 11-12 years could improve immunization coverage which is insufficient nowadays.
Databáze: OpenAIRE
Externí odkaz: